The Pathophysiological Role of Angiotensin Receptor-Binding Protein in Hypertension and Kidney Diseases: Oshima Award Address 2019

Clinical and Experimental Nephrology - Japan
doi 10.1007/s10157-020-01861-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Reverse Translational Research of Autophagy and Metabolism in Kidney Disease: Oshima Award Address 2018

Clinical and Experimental Nephrology
PhysiologyNephrology
2019English

Novel Tubular–glomerular Interplay in Diabetic Kidney Disease Mediated by Sirtuin 1, Nicotinamide Mononucleotide, and Nicotinamide Adenine Dinucleotide Oshima Award Address 2017

Clinical and Experimental Nephrology
PhysiologyNephrology
2019English

Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II Induced Hypertension

Hypertension
Internal Medicine
1999English

The Renin-Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition

Journal of Managed Care Pharmacy
2007English

The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases

Drug Safety
ToxicologyPharmacology
2014English

Pathophysiological Role of Cation Transport and Natriuretic Factors in Hypertension.

Hypertension
Internal Medicine
1987English

Pathophysiological Role of Dopamine on the Development of Hypertension in Rats.

Japanese Circulation Journal
1987English

The Angiotensin II Type 1 Receptor Blocker Olmesartan Preferentially Improves Nocturnal Hypertension and Proteinuria in Chronic Kidney Disease

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2012English

Kidney and Hypertension: Role of the Juxtaglomerular Apparatus.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy